Single nucleotide polymorphisms present on the promoter sequence of the TNF-a gene may affect production of TNF-a, a pro-inflammatory cytokine, during immune responses. The presence of TNF-a polymorphisms is also reportedly associated with more severe manifestations of Helicobacter pylori infection. However, the frequency of TNF-a polymorphisms and the associated disease severity vary between different patient groups. In this study, gastric biopsies and blood specimens were collected from 138 patients with dyspepsia undergoing routine upper gastrointestinal endoscopy. Our institution's Ethics Review Committee approved the study and written informed consent was obtained from all participants. The presence of H. pylori was confirmed histologically in all patients. The frequency of TNF-a polymorphisms in the study cohort was investigated using PCR-restriction fragment length polymorphism and expression of serum TNF-a quantitated using a commercial ELISA assay. The proportions of selected TNF-a polymorphisms (TNF-a -238, -308 and -863) were similar in H. pylori-positive and -negative patients. Homozygous mutations of TNF-a polymorphisms were rarely detected in the study group. There was a significant difference in TNF-a concentrations between patients with mild chronic gastritis and TNF-a -308 GG genotype and patients with moderate to severe chronic gastritis (P ¼ 0.008). It was not possible to identify an association between these genotypes and disease severity because of the low frequency of heterozygous and homozygous mutated genes in Sri Lankan patients with dyspepsia.
substitution, whereas -863 polymorphisms involve C to A substitution at position 863 (11) .
The association between TNF-a -308 and TNF-a -238 polymorphisms and gastric pathology is still controversial (12) . A meta-analysis identified TNF-a polymorphisms as a risk factor for gastric cancer in Caucasian, but not in East Asian and other Asian, individuals (12) (13) (14) . Similarly Gorouhi et al., reported that the association between TNF-a -308 (G/A) and gastric cancer was limited to western populations (15) . Several studies from China (16) and Korea (17) have not found an association between the TNF-a genotype and gastric pathology, whereas other studies have reported an association (18, 19) .
The role of TNF-a polymorphisms in severity of H. pylori-associated disease has not been studied in Sri Lanka. Previous histological studies done in Sri Lanka have suggested that most H. pylori-infected patients have mild chronic gastritis (20, 21) and that development of gastric atrophy is not a significant problem. Multiple factors can contribute to a shift from mild to atrophic gastritis; however, host genetic factors can play a major role. In this study we investigated polymorphisms of the TNF-a gene in Sri Lankan individuals and their correlation with H. pylori-associated disease severity. We hypothesized that TNF-a may be a useful genotypic marker for identifying groups at higher risk of gastric cancer and peptic ulcer and therefore those for whom preventive H. pylori eradication therapy should be considered.
MATERIALS AND METHODS

Study cohort
The study cohort consisted of patients undergoing routine endoscopy at a tertiary care hospital in Sri Lanka for dyspeptic symptoms. Other inclusion criteria were age over 18 years and no antibiotics for a month before endoscopy. Patients aged less than 18 years, currently on antibiotics or with a history of antibiotic intake in the previous 4 weeks, with mental instability or with malignant diseases (e.g., gastric cancer) were excluded. Written informed consent was obtained before enrolling patients in the study. An interviewer-based questionnaire was used to collect patient data.
Ethical approval
Approval for the study was obtained from the Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura (Application no: 14/15) and Colombo South Teaching Hospital, Kalubowila (Application no: 450).
Specimen collection
Four antral gastric biopsy specimens were collected from each patient during endoscopy. One specimen was placed in an in-house rapid urease test solution, two in 10% formalin saline solution, and the remaining one in a sterile Eppendorf tube. The specimens were transported to the Departments of Pathology and Microbiology for processing. A blood specimen (5 mL) was collected from each patient and centrifuged. The serum was aliquoted into cryovials and stored at À80°C.
Histopathological investigations
The biopsy specimens (transported in 10% formalin saline) were dehydrated using an alcohol gradient, placed in xylene and embedded in paraffin wax. Sections were cut using a microtome (4 mm thick) and placed on clean glass slides. The slides were stained with hematoxylin and eosin and Giemsa stains separately. Specimens were graded according to the updated Sydney system (22) by an experienced consultant pathologist.
In-house biopsy urease test
The specimen placed in the in-house rapid urease test solution was placed in an incubator (37°C) for 24 hr. The solution was observed at 1, 2, 12 and 24 hr intervals for color change from yellow-orange to pink-red.
DNA extraction, PCR and RFLP
In accordance with the manufacturer's instructions, DNA was extracted from the remaining biopsy specimen using a commercial DNA extraction kit (QIAamp DNA mini kit; Qiagen, Hilden, Germany). PCR was performed on DNA extracted from each specimen using the specific primers listed in Table 1 to amplify the promoter region of the TNF-a gene (11) .
All PCR reactions were carried out using Flexigene thermal cycler (version 31.04; Techne, Cole-Parmer, Staffordshire, UK). All PCR reactions were performed in a 25 mL reaction mixture consisting of 1Â buffer (Sigma-Aldrich, St Louis, MO, USA) with 0.2 mM each of dATP, dCTP, dGTP and dTTP (Promega, Madison, WI, USA), 0.2 mM of forward and reverse primer, 1.25 U of Taq polymerase (Sigma-Aldrich) and 2 mL ($100 ng) of nucleic acid (Table 1) .
TNF-a polymorphisms were determined by digesting the three PCR products with specific restriction enzymes (11) . RFLP reactions were optimized by digesting lambda DNA with each of the restriction enzymes. Optimized RFLP conditions were applied to DNA extracted from patient specimens: the RFLP reactions were carried out in 15 mL reaction volumes consisting of 1Â reaction buffer, restriction enzyme and PCR products. For TNF-a -238 polymorphism, 5 mL of PCR products and 5 U of Msp I enzyme (Promega) was used with 2 mg of BSA (Promega) and digested for 4 hr at 37°C. PCR products (6 mL) for the TNF-a -308 polymorphism were digested for 16 hr at 37°C with 1 U of Nco I enzyme. The restriction enzymes Msp I and Nco I were inactivated by keeping the reaction mixture at 65°C for 20 min. For the TNF-a -863 polymorphism, 5 mL of PCR products were mixed with 5 U of Tai I enzyme and incubated at 65°C for 3 hr. EDTA (20 mM) was added to inactivate the enzyme.
PCR products were visualized by running on a 1.5% agarose gel while the RFLP products were visualized in a 3% agarose gel under a UV transilluminator (Quantum ST4; Vilber Lourmat, Marne-la-Vall ee, France).
When the PCR product of TNF-a -238 (151 bp) is digested by Msp I, the wild type (TNF-a -238 GG) will yield one band at 132 bp (a 19 bp band is not visible) and the heterozygous genotype (TNF-a -238 GA) two separate bands (132 bp and 151 bp), whereas specimens containing the mutated genotype (TNF-a -238 AA) will result in undigested PCR product. For TNF-a -308 polymorphism, wild type (TNF-a -308 GG) specimens yield one band at 126 bp (a 18 bp band is not visible) and heterozygous specimens (TNF-a -308 GA) yield two separate bands at 144 bp and 126 bp, whereas the mutated genotype (TNF-a -308 AA) remains undigested. The wild type genotype of TNF-a -863 (TNF-a -863 CC) remains undigested whereas the heterozygous genotype (TNF-a -863 CA) yields two bands at 125 bp and 104 bp and the mutated genotype (TNF-a -863 AA) one band at 104 bp.
Expression of TNF-a in serum specimens of H. pylori-positive patients TNF-a concentrations in serum specimens were measured using an ELISA assay (Mabtech AB, Nacka Strand, Sweden) according to the manufacturer's instructions. Two wells (blank) were kept empty while an ELISA plate was coated with mAb TNF3/4 and incubated overnight at 4°-8°C. The serum specimens and plate were allowed to reach room temperature (20°-25°C) and the coated plate washed with PBS solution. Blocking solution (PBS with 0.05% Tween 20 with 0.1% BSA) was added to each well (except blanks) and incubated at room temperature for 1 hr. The plate was washed with washing buffer (PBS with 0.05% Tween) and standards and specimens were added in duplicate. The plate was then incubated for 2 hr at room temperature. After washing the plate with wash buffer, mAb TNF5-biotin solution was added to each well (except blanks) and incubated at room temperature for 1 hr. The plate was again washed and Streptavidin-HRP solution added before incubating for another hour at room temperature. After washing, substrate solution was added and allowed to incubate for 45 min before adding the stop solution. The absorbance at 450 nm was measured using an MPSCREEN MR-96A ELISA reader (MP Biomedicals, Santa Ana, CA, USA). The amount of TNF-a in each specimen was calculated using Graphpad Prism version 7 (Graphpad Software).
Data analysis
The frequency of the TNF-a polymorphisms was calculated as a percentage of the study cohort. The x 2 test was used to determine the association between TNF-a polymorphisms and H. pylori infection. Using the Mann-Whitney U test, serum TNF-a concentrations were compared between H. pylori-positive patients with mild chronic gastritis and H. pylori-positive patients with moderate to severe gastritis. 
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RESULTS
Characteristics of the study cohort
The study cohort consisted of 138 patients with dyspepsia aged from 18-87 years. Seventy-seven were male and 61 female. The cohort comprised study 22 H. pylori-positive and 116 H. pylori-negative patients (H. pylori infection confirmed by histology). Of the 22 H. pylori-positive patients, 13 had mild chronic gastritis and nine moderate to severe chronic gastritis, whereas most patients in the H. pylori-negative group (114/116) had mild chronic gastritis and two had moderate to severe chronic gastritis.
Association between TNF-a polymorphisms and H. pylori infection
The frequency of TNF-a polymorphisms among 22 H. pylori-positive and 116 H. pylori-negative patients is presented in Table 2 . Most patients in both the H. pyloripositive and negative groups had the wild type genotype. Among the 22 H. pylori positive patients, one patient was found to have each of the TNF-a -238 AA genotype (4.5%), TNF-a -308 AA genotype (4.5%) and TNF-a -863 AA (4.5%) genotype, whereas wild type genotypes were identified in 18 (81.8%) (TNF-a -238 GG), 20 (90.9%) (TNF-a -308 GG) and 15 (68.2%) (TNF-a -863 CC) of these patients. There was no significant difference in genotype expression between the H. pylori-positive and -negative groups.
When serum TNF-a expression in H. pylori-positive patients with dyspepsia (n ¼ 22) was compared with that in healthy H. pylori-negative individuals (n ¼ 44), the mean TNF-a concentration was found to be 224.6 pg/mL for H. pylori-positive patients whereas it was 276.4 pg/mL in the H. pylori-negative group. The difference in serum TNF-a expression between these two groups is not significant (P ¼ 0.4414).
Association of TNF-a polymorphisms and TNF-a cytokine expression in patients with H. pylori infection
Among the H. pylori-positive patients with the TNF-a -238 GG genotype, the mean TNF-a concentration was 139.89 pg/mL, whereas patients with TNF-a -238 GA genotype had a comparatively higher mean TNF-a concentration of 507.86 pg/mL and a patient with TNF-a -238 AA genotype had the highest TNF-a concentration of 984.69 pg/mL. Among patients with the TNF-a -308 GG genotype, the mean TNF-a concentration was 158.65 pg/mL. Two patients, one with TNF-a -308 GA genotype and another with TNF-a -308 AA genotype, had 27.79 pg/mL TNF-a in serum. Among patients with TNF-a -863 CC genotype, the mean concentration of TNF-a was 158.65 pg/mL, whereas among patients with TNF-a -863 CA genotype, the mean concentration was 124.89 pg/mL (Table 3) .
Frequency of TNF-a polymorphisms, TNF-a concentrations and their association with severity of chronic gastritis in H. pylori-positive patients Among the 22 patients with H. pylori infection and TNF-a -238 GG genotype, the 11 with mild chronic gastritis had a mean TNF-a concentration of 218.14 pg/mL, whereas those with moderate to severe chronic gastritis had a mean concentration of Table 2 . Association of TNF-a polymorphisms with H. pylori infection in the study cohort Table 4) .
Association of TNF-a polymorphisms with severity of chronic gastritis in H. pylori-negative patients Only two of 116 H. pylori-negative patients had moderate to severe gastritis, whereas the other 114 had mild chronic gastritis. Mild chronic gastritis was diagnosed in 91 patients (78.4%) with the TNF-a -238 GG genotype, 101 (87.1%) with TNF-a -308 GG genotype and 75 (64.7%) with TNF-a 863 CC genotype. Twelve patients with TNF-a -308 GA genotype and one with TNF-a -308 AA genotype were diagnosed as having mild chronic gastritis. None of the patients with moderate to severe chronic gastritis carried the TNF-a -238 GA or AA genotypes. Both patients with moderate to severe chronic gastritis had the wild type genotype for TNF-a -238 and -308 polymorphisms (Table 5) .
DISCUSSION
In the current study, we investigated three TNF-a polymorphisms in a Sri Lankan cohort: TNF-a -308, TNF-a -238 and TNF-a -863. None of the three polymorphisms was significantly associated with H. pylori infection or disease severity in our patient cohort.
Additionally, none of our Sri Lankan cohort was diagnosed with gastric atrophy, indicating a low risk of developing gastric cancer, which is a favorable finding for Sri Lankans. For all three gene polymorphisms, the wild type genotype was predominant among H. pyloripositive patients with mild gastritis and those with moderate to severe gastritis. However, TNF-a concentrations were significantly higher in patients with moderate to severe gastritis regardless of their TNF-a polymorphisms, suggesting that gene polymorphism alone is not responsible for the enhanced expression of TNF-a seen in patients with moderate to severe gastritis. TNF-a -308 heterozygous (GA) and mutant (AA) genotypes were found to be associated with an increased risk of gastric cancer in a Chinese study (23) . Further, Jang et al. reported that patients with gastric cancer tended to carry the TNF-a -308 A allele and that they found the homozygous A/A genotype in these patients from South Korea (24) . Among the 22 H. pylori positive patients in our study, the mutant TNF-a -308 AA genotype was not found in patients with mild gastritis and only one patient with this genotype had moderate to severe gastritis. The absence of gastric atrophy in our study cohort may be partly attributable to the predominance of the wild type genotype of TNF-a -308 and the rare occurrence of the AA genotype in Sri Lanka. Studies by Samaranayake et al. and Fernando et al. have reported a low proportion of AA genotype in Sri Lanka (25, 26) , strengthening our findings. Thus, we hypothesized that TNF-a -308 polymorphism may be useful as a genotypic marker for identifying groups at higher risk of gastric cancer and peptic ulcer, and thus for whom prevention of these diseases by H. pylori eradication therapy is indicated.
Studies investigating the association between TNF-aÀ238 polymorphism and risk of gastric diseases have yielded contradictory and inconclusive results. No significant association was found between the TNF-a -238 GA genotype and gastric cancer in a Chinese cohort (23) , whereas a meta-analysis concluded that the TNF-a -238 GA genotype is significantly associated with increased gastric cancer risk among Asians (27) . In the present study, the TNF-a -238 AA and GA genotypes were rare, making it impossible to identify an association between the presence of TNF-a -238 A allele and severity of H. pylori-associated disease in Sri Lankan individuals. TNF-a -863 polymorphisms have been studied in a Japanese cohort and found to be associated with increased risk of development of gastric ulcer and gastric cancer in patients with TNF-a 863 A allele (18) . Among patients with dyspepsia in Taiwan, those with the TNF-a -863 A allele reportedly have significantly more numerous neutrophils and a higher risk of ulcer development (28) . However, in our Sri Lankan cohort, TNF-a -863 polymorphism was not significantly associated with H. pylori infection or severity of gastritis. The low frequency or absence of CA and AA genotypes in our cohort made it impossible to draw conclusions about the roles of these genotypes in development of complications such as gastric cancer.
The low frequency of mutated and heterozygous TNF-a polymorphisms among patients with dyspepsia in our Sri Lankan study cohort emphasizes the importance of ensuring a larger sample size to improve the statistical power, its small size being a limitation of the present study.
In conclusion, the wild type genotype of TNF-a was predominant in our Sri Lankan study cohort, preventing us from finding and no clear association between H. pylori infection and gene polymorphism. Our findings on the frequency of TNF-a polymorphisms indicate that larger studies are needed to investigate the association of these gene polymorphisms with H. pylori infection and associated disease severity. 
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